US Patent

US11090186 — Methods for using intrauterine systems and IUD insertion devices

Method of Use · Assigned to Medicines360 · Expires 2033-10-24 · 7y remaining

Vulnerability score 45/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects methods for using intrauterine systems, including insertion devices and procedures for inserting intrauterine devices into a female patient's cervix.

USPTO Abstract

The present disclosure is related to methods of using an intrauterine system (insertion device) including an intrauterine device (IUD), an insertion device or applicator for inserting the IUD into the cervix of a female patient, methods related to the insertion procedure, and methods of manufacture for the insertion device.

Drugs covered by this patent

Jadelle (LEVONORGESTREL) · Fdn Consumer

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2348`	—	Jadelle

Patent Metadata

Patent number: US11090186
Jurisdiction: US
Classification: Method of Use
Expires: 2033-10-24
Drug substance claim: No
Drug product claim: No
Assignee: Medicines360
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.